Tian X

ORCID: 0000-0003-4620-5338 · 33 papers in corpus
meta-analysis 2017
Oncotarget ·doi:10.18632/oncotarget.15759

Ovarian reserve reflects a woman's fertility potential. The ABO blood group system is a very stable genetic marker. Although many recent studies have explored the relationship between ABO blood group and ovarian reserve, a consensus has not…

2017
BMC complementary and alternative medicine
observational 2016
Oncotarget ·doi:10.18632/oncotarget.8245

BACKGROUND: Most cervical cancer patients worldwide receive surgical treatments, and yet the current International Federation of Gynecology and Obstetrics (FIGO) staging system do not consider surgical-pathologic data. We propose a more com…

observational 2016
PloS one ·doi:10.1371/journal.pone.0165097

OBJECTIVE: This study aimed to assess the trend of human fecundity over time in China. METHODS: This retrospective study was conducted in Tongliao, China. Couples who were married during the time period between January 1, 1981 and December…

observational 2015
Nan fang yi ke da xue xue bao = Journal of Southern Medical University

OBJECTIVE: To explore the effects of uterine adenomyosis on the clinical outcomes of infertility patients treated with in vitro fertilization/intracytoplasmic sperm injection-embryo transfer (IVF/ICSI-ET). METHODS: A retrospective study wa…

lab-animal 2015
International journal of clinical and experimental pathology

Emerging evidence showed that miRNA dysregulation is involved in the development of endometriosis and may contribute to pathological process of endometriosis associated ovarian cancer (EAOC). miR-191 is one of the most differentially expres…

other 2014
Cancer research ·doi:10.1158/0008-5472.can-14-1706

Advanced technologies and biomaterials developed for tissue engineering and regenerative medicine present tractable biomimetic systems with potential applications for cancer research. Recently, the National Cancer Institute convened a Strat…

lab-animal 2014
Oncology research ·doi:10.3727/096504015x14410238486720

Triptorelin, a kind of GnRH agonist, is widely used in the treatment of hormone-responsive cancers in the clinic. This study aimed to discover the underlying mechanism of triptorelin in protection from 5-fluorouracil (5-FU)-induced ovarian …